Chargement en cours...

Efficacy and safety evaluation of icotinib in patients with advanced non-small cell lung cancer

OBJECTIVE: To evaluate the efficacy and safety of icotinib hydrochloride in patients with advanced non-small cell lung cancer (NSCLC). METHODS: A total of 89 patients with stage IIIB or IV NSCLC received icotinib at a dose of 125 mg administered 3 times a day. Icotinib treatment was continued until...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Gu, Aiqin, Shi, Chunlei, Xiong, Liwen, Chu, Tianqing, Pei, Jun, Han, Baohui
Format: Artigo
Langue:Inglês
Publié: AME Publishing Company 2013
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3555305/
https://ncbi.nlm.nih.gov/pubmed/23372346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.1000-9604.2012.12.07
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!